MarketCap
Facebook
X
TelegramQuarterly report 2024-Q2
added 05-16-2026
Atrion Corporation General and Administrative Expenses 2011-2026 | ATRI
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Atrion Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.2 K | 20.9 K | 19.6 K | 17.3 M | 16.3 M | 16.2 M | 16.4 M | 15.3 M | 16.1 M | 16.2 M | 14.6 M | 13.1 M | 13.6 M | 11.9 M | 11.6 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17.3 M | 19.6 K | 11.9 M |
Quarterly General and Administrative Expenses Atrion Corporation
| 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.3 M | 4.79 M | 5.45 M | 5.95 M | 6.25 M | - | 4.49 M | 5.62 M | 5.1 M | - | 4.84 M | 4.75 M | 4.17 M | - | 4.04 M | 4.63 M | 4.4 M | - | 3.99 M | 4.3 M | 4.19 M | - | 3.93 M | 4.31 M | 4.23 M | - | 4.09 M | 4.29 M | 4.02 M | - | 3.61 M | 3.88 M | 3.95 M | - | 3.93 M | 4.31 M | 3.96 M | - | 4.15 M | 4.39 M | 3.93 M | - | 3.65 M | 3.71 M | 3.59 M | - | 3.16 M | 3.4 M | 3.47 M | - | 3.29 M | 3.95 M | 3.38 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 11.3 M | 3.16 M | 4.41 M |
General and Administrative Expenses of other stocks in the Medical instruments industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
1.63 B | $ 66.58 | 7.35 % | $ 13.3 B |  USA |
 |
Glaukos Corporation
GKOS
|
332 M | $ 125.97 | 3.43 % | $ 7.2 B | USA |
 |
Luminex Corporation
LMNX
|
140 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
3.73 M | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
2.38 B | $ 425.91 | 1.69 % | $ 152 B | USA |
 |
Alcon
ALC
|
251 M | $ 66.88 | 0.48 % | $ 40.4 B |  Schweiz |
 |
ICU Medical
ICUI
|
625 M | $ 137.7 | 2.05 % | $ 3.39 B | USA |
 |
iRhythm Technologies
IRTC
|
493 M | $ 108.22 | 0.81 % | $ 3.46 B | USA |
 |
LeMaitre Vascular
LMAT
|
42 M | $ 94.72 | 1.24 % | $ 2.14 B | USA |
 |
Repro Med Systems
KRMD
|
23.4 M | $ 3.97 | -4.1 % | $ 183 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
62.8 M | - | - | $ 955 M | USA |
 |
Masimo Corporation
MASI
|
744 M | $ 178.94 | 0.02 % | $ 9.54 B | USA |
 |
Cantel Medical Corp.
CMD
|
198 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
8.44 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
941 M | - | -0.05 % | $ 10.3 B | USA |
 |
Microbot Medical
MBOT
|
8.46 M | $ 1.86 | -5.36 % | $ 85.2 M |  Israel |
 |
Ekso Bionics Holdings
EKSO
|
9.99 M | - | - | $ 28.6 M | USA |
 |
Milestone Scientific
MLSS
|
11.6 M | $ 0.4 | -6.09 % | $ 32.8 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
671 M | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
38.2 M | $ 8.97 | -9.76 % | $ 76.1 K | USA |
 |
Envista Holdings Corporation
NVST
|
1.16 B | $ 22.92 | 0.24 % | $ 3.85 B | USA |
 |
Haemonetics Corporation
HAE
|
442 M | $ 71.48 | 2.38 % | $ 3.37 B | USA |
 |
Isoray
ISR
|
30.2 M | - | 0.03 % | $ 108 M | USA |
 |
STERIS plc
STE
|
1.41 B | $ 212.3 | 0.01 % | $ 20.8 B | USA |
 |
STAAR Surgical Company
STAA
|
85.8 M | $ 29.94 | 0.27 % | $ 1.48 B | USA |
 |
InfuSystem Holdings
INFU
|
57 M | $ 9.24 | 1.32 % | $ 191 M | USA |
 |
Utah Medical Products
UTMD
|
7.88 M | $ 68.63 | 0.93 % | $ 222 M | USA |
 |
Teleflex Incorporated
TFX
|
720 M | $ 131.84 | -0.17 % | $ 5.88 B | USA |
 |
Merit Medical Systems
MMSI
|
455 M | $ 64.39 | 2.13 % | $ 3.81 B | USA |
 |
West Pharmaceutical Services
WST
|
394 M | $ 318.73 | 0.46 % | $ 23 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.44 B | $ 9.92 | 0.4 % | $ 1.98 B | USA |
 |
Pulse Biosciences
PLSE
|
32 M | $ 25.4 | -5.73 % | $ 1.71 B | USA |
 |
Retractable Technologies
RVP
|
12.8 M | $ 0.66 | -0.03 % | $ 19.8 M | USA |
 |
Pro-Dex
PDEX
|
4.84 M | $ 67.09 | 0.13 % | $ 221 M | USA |
 |
Predictive Oncology
POAI
|
25.9 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
45.5 M | $ 26.44 | -2.4 % | $ 1.26 B | USA |
 |
Stereotaxis
STXS
|
17.8 M | $ 1.81 | -3.73 % | $ 165 M | USA |
 |
Baxter International
BAX
|
2.89 B | $ 19.41 | 0.28 % | $ 9.96 B | USA |
 |
ResMed
RMD
|
739 M | $ 197.02 | 1.4 % | $ 28.8 B | USA |
 |
AtriCure
ATRC
|
311 M | $ 27.46 | 0.71 % | $ 1.31 B | USA |
 |
Harvard Bioscience
HBIO
|
17.7 M | $ 6.16 | -5.02 % | $ 273 M | USA |
 |
NeuroMetrix
NURO
|
6.33 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
42.1 M | $ 12.27 | 2.0 % | $ 501 M | USA |
 |
Becton, Dickinson and Company
BDX
|
5.28 B | $ 152.5 | 2.02 % | $ 43.9 B | USA |
 |
Nephros
NEPH
|
9 M | $ 3.5 | -2.51 % | $ 37.1 M | USA |
 |
OraSure Technologies
OSUR
|
47.7 M | $ 4.04 | -3.12 % | $ 297 M | USA |
 |
Repligen Corporation
RGEN
|
291 M | $ 123.19 | -2.66 % | $ 6.93 M | USA |